CompletedNCT00527683
Vigabatrin or placebo for cocaine dependence
About this title
Read the official source — NCT00527683Medication studyAges 18–55MexicoAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Mexico CitySee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateApril 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- NYU Langone Health
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Mexico
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00527683
- Official title
Show the full official title
Double-Blind, Randomized, Placebo- Controlled Trial of Vigabatrin for Short Term Abstinence From Cocaine in Cocaine Dependent Parolees
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Mexico City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is NYU Langone Health.
Did this study involve medication?
Yes. The study involved medication, including Vigabatrin and Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
Want to explore more studies?
Explore studiesRelated studies
A Non-Inferiority Trial of an Electronic vs Face-to-face Brief Intervention After Alcohol Screening in Two Countries
Brief Contextual-Behavioral vs Twelve-Step Intervention for Emotion Regulation in Substance Use: Pilot Study
